131 related articles for article (PubMed ID: 1869297)
61. Biochemical and behavioral responses of pilocarpine at muscarinic receptor subtypes in the CNS. Comparison with receptor binding and low-energy conformations.
Hoss W; Woodruff JM; Ellerbrock BR; Periyasamy S; Ghodsi-Hovsepian S; Stibbe J; Bohnett M; Messer WS
Brain Res; 1990 Nov; 533(2):232-8. PubMed ID: 1963109
[TBL] [Abstract][Full Text] [Related]
62. Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology.
Doods HN; Quirion R; Mihm G; Engel W; Rudolf K; Entzeroth M; Schiavi GB; Ladinsky H; Bechtel WD; Ensinger HA
Life Sci; 1993; 52(5-6):497-503. PubMed ID: 8441330
[TBL] [Abstract][Full Text] [Related]
63. Adrenocorticotropic hormone (ACTH) and centrally-acting cholinomimetic drugs improve survival of rats with severe hemorrhagic shock through distinct central cholinergic mechanisms.
Bertolini A; Ferrari W; Guarini S
Resuscitation; 1989 Dec; 18(2-3):289-97. PubMed ID: 2555880
[TBL] [Abstract][Full Text] [Related]
64. The effects of cholinergic drugs support an avoidance learning hypothesis of brief footshock-induced analgesia.
Gower AJ; Tricklebank MD
Neuropharmacology; 1986 Oct; 25(10):1161-6. PubMed ID: 3785583
[TBL] [Abstract][Full Text] [Related]
65. Reciprocal hindlimb scratching and putative subtype-selective muscarinic agents.
Raffa RB; Ortegón ME; Watson M
Eur J Pharmacol; 1988 Dec; 158(3):289-92. PubMed ID: 3253103
[TBL] [Abstract][Full Text] [Related]
66. The muscarinic receptor agonist BuTAC, a novel potential antipsychotic, does not impair learning and memory in mouse passive avoidance.
Rasmussen T; Fink-Jensen A; Sauerberg P; Swedberg MD; Thomsen C; Sheardown MJ; Jeppesen L; Calligaro DO; DeLapp NW; Whitesitt C; Ward JS; Shannon HE; Bymaster FP
Schizophr Res; 2001 Apr; 49(1-2):193-201. PubMed ID: 11343877
[TBL] [Abstract][Full Text] [Related]
67. Cholinergic agonists suppress play fighting in juvenile rats.
Wilson LI; Bierley RA; Beatty WW
Pharmacol Biochem Behav; 1986 May; 24(5):1157-9. PubMed ID: 3725822
[TBL] [Abstract][Full Text] [Related]
68. Improving the oral efficacy of CNS drug candidates: discovery of highly orally efficacious piperidinyl piperidine M2 muscarinic receptor antagonists.
Wang Y; Chackalamannil S; Hu Z; Greenlee WJ; Clader J; Boyle CD; Kaminski JJ; Billard W; Binch H; Crosby G; Ruperto V; Duffy RA; Cohen-Williams M; Coffin VL; Cox KA; Grotz DE; Lachowicz JE
J Med Chem; 2002 Dec; 45(25):5415-8. PubMed ID: 12459007
[TBL] [Abstract][Full Text] [Related]
69. The effects of microinjection of the selective blocker of muscarinic M1 receptors pirenzepine into the neostriatum on the motor behavior of rats.
Shapovalova KB; Kamkina YV; Mysovskii DA
Neurosci Behav Physiol; 2005 Jul; 35(6):589-94. PubMed ID: 16342615
[TBL] [Abstract][Full Text] [Related]
70. Hippocampal theta rhythm involvement in cholinergic-induced blockade of discriminated avoidance responding in rats.
Erickson CK; Chalmers RK
Arch Int Pharmacodyn Ther; 1966 Sep; 163(1):70-8. PubMed ID: 5970858
[No Abstract] [Full Text] [Related]
71. Synthesis and muscarinic activity of a series of quinolines and naphthalenes with a 1-azabicyclo[3.3.0]octane moiety.
Suzuki T; Usui T; Oka M; Suzuki T; Kataoka T
Chem Pharm Bull (Tokyo); 1998 Aug; 46(8):1265-73. PubMed ID: 9734314
[TBL] [Abstract][Full Text] [Related]
72. CI-1017, a functionally M1-selective muscarinic agonist: design, synthesis, and preclinical pharmacology.
Tecle H; Schwarz RD; Barrett SD; Callahan MJ; Caprathe BW; Davis RE; Doyle P; Emmerling M; Lauffer DJ; Mirzadegan T; Moreland DW; Lipiniski W; Nelson C; Raby C; Spencer C; Spiegel K; Thomas AJ; Jaen JC
Pharm Acta Helv; 2000 Mar; 74(2-3):141-8. PubMed ID: 10812951
[TBL] [Abstract][Full Text] [Related]
73. Muscarinic agonist-mediated induction of long-term potentiation in rat cerebral cortex.
Lin Y; Phillis JW
Brain Res; 1991 Jun; 551(1-2):342-5. PubMed ID: 1680527
[TBL] [Abstract][Full Text] [Related]
74. Hippocampal muscarinic receptor loss following trimethyl tin administration.
Loullis CC; Dean RL; Lippa AS; Clody DE; Coupet J
Pharmacol Biochem Behav; 1985 Jan; 22(1):147-51. PubMed ID: 3975239
[TBL] [Abstract][Full Text] [Related]
75. Enhanced flexibility of place discrimination learning by targeting striatal cholinergic interneurons.
Okada K; Nishizawa K; Fukabori R; Kai N; Shiota A; Ueda M; Tsutsui Y; Sakata S; Matsushita N; Kobayashi K
Nat Commun; 2014 May; 5():3778. PubMed ID: 24797209
[TBL] [Abstract][Full Text] [Related]
76. Synthesis and structure-activity studies of a series of spirooxazolidine-2,4-diones: 4-oxa analogues of the muscarinic agonist 2-ethyl-8-methyl-2,8-diazaspiro[4.5]decane-1,3-dione.
Tsukamoto S; Ichihara M; Wanibuchi F; Usuda S; Hidaka K; Harada M; Tamura T
J Med Chem; 1993 Aug; 36(16):2292-9. PubMed ID: 8360873
[TBL] [Abstract][Full Text] [Related]
77. Muscarinic activity of the thiolactone, lactam, lactol, and thiolactol analogues of pilocarpine and a hypothetical model for the binding of agonists to the m1 receptor.
Shapiro G; Floersheim P; Boelsterli J; Amstutz R; Bolliger G; Gammenthaler H; Gmelin G; Supavilai P; Walkinshaw M
J Med Chem; 1992 Jan; 35(1):15-27. PubMed ID: 1732522
[TBL] [Abstract][Full Text] [Related]
78. Synthesis and cholinergic properties of bis[[(dimethylamino)methyl]furanyl] analogues of ranitidine.
Sowell JW; Tang Y; Valli MJ; Chapman JM; Usher LA; Vaughan CM; Kosh JW
J Med Chem; 1992 Mar; 35(6):1102-8. PubMed ID: 1552502
[TBL] [Abstract][Full Text] [Related]
79. Enhancement by secoverine and physostigmine of retention of passive avoidance response in mice.
Gower AJ
Psychopharmacology (Berl); 1987; 91(3):326-9. PubMed ID: 3104954
[TBL] [Abstract][Full Text] [Related]
80. The effect of pirenzepine on spatial learning in the Morris Water Maze.
Hunter AJ; Roberts FF
Pharmacol Biochem Behav; 1988 Jun; 30(2):519-23. PubMed ID: 3174783
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
